These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8653701

  • 1. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.
    Ranganathan S, Dexter DW, Benetatos CA, Chapman AE, Tew KD, Hudes GR.
    Cancer Res; 1996 Jun 01; 56(11):2584-9. PubMed ID: 8653701
    [Abstract] [Full Text] [Related]

  • 2. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S, McCauley RA, Dexter DW, Hudes GR.
    Br J Cancer; 2001 Sep 01; 85(5):735-40. PubMed ID: 11531260
    [Abstract] [Full Text] [Related]

  • 3. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.
    Ranganathan S, Dexter DW, Benetatos CA, Hudes GR.
    Biochim Biophys Acta; 1998 Jan 21; 1395(2):237-45. PubMed ID: 9473684
    [Abstract] [Full Text] [Related]

  • 4. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.
    Nicoletti MI, Valoti G, Giannakakou P, Zhan Z, Kim JH, Lucchini V, Landoni F, Mayo JG, Giavazzi R, Fojo T.
    Clin Cancer Res; 2001 Sep 21; 7(9):2912-22. PubMed ID: 11555610
    [Abstract] [Full Text] [Related]

  • 5. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
    Speicher LA, Barone L, Tew KD.
    Cancer Res; 1992 Aug 15; 52(16):4433-40. PubMed ID: 1353706
    [Abstract] [Full Text] [Related]

  • 6. Interaction of estramustine with tubulin isotypes.
    Laing N, Dahllöf B, Hartley-Asp B, Ranganathan S, Tew KD.
    Biochemistry; 1997 Jan 28; 36(4):871-8. PubMed ID: 9020786
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry.
    Verdier-Pinard P, Wang F, Martello L, Burd B, Orr GA, Horwitz SB.
    Biochemistry; 2003 May 13; 42(18):5349-57. PubMed ID: 12731876
    [Abstract] [Full Text] [Related]

  • 11. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells.
    Banerjee A.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):598-601. PubMed ID: 12054644
    [Abstract] [Full Text] [Related]

  • 12. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP, Pasquier E, Kavallaris M.
    Cancer Res; 2007 Oct 01; 67(19):9356-63. PubMed ID: 17909044
    [Abstract] [Full Text] [Related]

  • 13. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H, Kearney CM, Pinney KG.
    Anticancer Res; 2005 Oct 01; 25(6B):3865-70. PubMed ID: 16309172
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.
    Isonishi S, Saitou M, Saitou M, Yasuda M, Tanaka T.
    Oncol Rep; 2007 Jul 01; 18(1):195-201. PubMed ID: 17549368
    [Abstract] [Full Text] [Related]

  • 15. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
    Eklöv S, Mahdy E, Wester K, Björk P, Malmström PU, Busch C, Nilsson S.
    Anticancer Res; 1996 Jul 01; 16(4A):1819-22. PubMed ID: 8712706
    [Abstract] [Full Text] [Related]

  • 16. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression.
    Sangrajrang S, Denoulet P, Laing NM, Tatoud R, Millot G, Calvo F, Tew KD, Fellous A.
    Biochem Pharmacol; 1998 Feb 01; 55(3):325-31. PubMed ID: 9484799
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A, Soprano DR, Parekh HK.
    Cancer Res; 2001 Oct 15; 61(20):7552-5. PubMed ID: 11606393
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.